The Medicines and Healthcare products Regulatory Agency of the United Kingdom has approvedlenacapavir, or Yeytuo, for the prevention of sexually transmitted HIV-1 infection in adults and adolescents, the regulator announced.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD:
- Top drugmakers to enter agreements with U.S. to cut drug prices, Reuters says
- Gilead appoints Keeley Wettan general counsel
- Gilead Sciences: Strategic Expansion in HIV Treatment Bolsters Buy Rating
- Gilead announces ARTISTRY-2 trial met primary success criterion
- The Week That Was, The Week Ahead: Macro & Markets, Dec. 14